Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionBnp Paribas
Latest Disclosed Ownership98,342 shares
Latest Disclosed Value $ 13,704,865
Bnp Paribas reports 6.25% increase in ownership of GILD / Gilead Sciences, Inc.

On May 12, 2026 - Bnp Paribas filed a 13F-HR form disclosing ownership of 98,342 shares of Gilead Sciences, Inc. (US:GILD) valued at $13,705,925 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 92,553 shares of Gilead Sciences, Inc.. This represents a change in shares of 6.25% during the quarter. The current value of the position is $12,685,135 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F GILEAD SCIENCES INC COM Equity 375558103 98,342 5,789 6.25 13,705 20.62 0.2562
2026-02-10 2025-12-31 13F GILEAD SCIENCES INC COM Equity 375558103 92,553 23,078 33.22 11,362 47.32 0.3251
2025-11-14 2025-09-30 13F GILEAD SCIENCES INC COM Equity 375558103 69,475 -16,020 -18.74 7,713 -18.60 0.2328
2025-08-14 2025-06-30 13F GILEAD SCIENCES INC COM Equity 375558103 85,495 150 0.18 9,474 -0.93 0.3075
2025-05-15 2025-03-31 13F GILEAD SCIENCES INC COM EQUITY 375558103 85,345 10,946 14.71 9,564 39.12 0.3964
2025-02-14 2024-12-31 13F GILEAD SCIENCES INC COM Equity 375558103 74,399 -2,996 -3.87 6,874 5.95 0.0410
2024-11-13 2024-09-30 13F GILEAD SCIENCES INC COM Equity 375558103 77,395 -4,020 -4.94 6,488 16.19 0.2694
2024-08-13 2024-06-30 13F GILEAD SCIENCES INC COM Equity 375558103 81,415 2,810 3.57 5,585 -3.02 0.2811
2024-05-02 2024-03-31 13F GILEAD SCIENCES INC COM Equities 375558103 78,605 78,605 5,758 0.2686
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.